According to a new report published by Allied Market Research, titled, “Transcriptomics Market by Technology, Products & Services, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global transcriptomics market was valued at $3,212 million in 2016, and is projected to reach $7,954 million by 2023, growing at a CAGR of 13.8% from 2017 to 2023. Real-time PCR segment held more than two-fifths share of the total market in 2016.

Increase in technological advancements and rise in research grants by various institutes is expected to drive the market growth. In addition, the potential of RNAs to act as candidates for diagnostic biomarkers and predictors of drug response are anticipated to further drive the demand for transcriptomics globally. However, standardization concerns over RNA sequencing and lack of skilled professionals restrict the market growth.

To Remain ‘Ahead’ Of Your Competitors, Request For A Sample at: https://www.alliedmarketresearch.com/request-sample/2595 

COVID-19 scenario analysis:

1) The COVID-19 impact on the Transcriptomics market is unpredictable and is expected to remain in force till the fourth quarter of 2021.

2) The COVID-19 outbreak forced governments across the globe to implement strict lockdowns and banned import-export of nonessential items for most of 2021. This led to sudden fall in the availability of important raw materials.

3) Moreover, nationwide lockdowns forced manufacturing facilities to partially or completely shut their operations.

4) Adverse impacts of the COVID-19 pandemic have resulted in delays in activities and initiatives regarding development of reliable and innovative drone analytics systems globally.

Inquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/request-for-customization/2595?reqfor=covid 

Key findings of Transcriptomics market:

•Drug discovery application led the overall transcriptomics market, and accounted for nearly three-fifths of the total market in 2016.

•Sequencing technology is projected to grow at highest CAGR of 15.1% during the forecast period.

•CROs are the fastest growing end user market for transcriptomics and are expected to witness CAGR of 14.1% during the forecast period.

•qPCR technology segment occupied nearly half of the global transcriptomics market in 2016.

•Japan is the major shareholder, accounting for more than one-third of the Asia-Pacific transcriptomics market in 2016.

North America accounted for the share of more than 45% of the overall market in 2016 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased funding for research institutes and increased incidence of chronic disorders such as cancer. However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period, at a CAGR of 15.7%.

List of Key Players Profiled in the Report:

The major players of the market includes QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Fluidigm Corporation, and Promega Corporation.

Interested in Procuring this Report? Visit Here: https://www.alliedmarketresearch.com/purchase-enquiry/2595 

Trending Reports In Healthcare Industry:
 
 
About Allied Market Research:
 
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
 
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.